Our impact
Investment for Purpose
Investment for Purpose (IFP) is MSWA’s financial commitment which address critical funding gaps, supporting key initiatives and opportunities and investing in ground-breaking research, directed toward improving the quality of life and better access to treatments for people living with a neurological condition.
FY24-25 Impact at a glance
*Results from MSWA's quarterly experience survey.
**NPS score measures willingness to recommend a company, product or service.
Strategic levers for impact
MSWA’s Five Year Strategy for 2025-2029 aims to empower people with neurological conditions to live their best lives. We have continued to make significant strides in our key levers for impact to create the most impact and difference to the community.
Looking ahead
By continuously listening to valuable Client feedback and addressing the challenges within the sector, MSWA remains focused on improving service delivery and keeping Clients at the centre of everything they do. This approach enables the team to effectively implement the key strategic levers for impact, now and into the future.
-
Investment for Purpose
Support expansion of Outreach and enhance community engagement programs.
Launch the new Life not Limits Grant: In memory of Ros Harman to help Clients pursue personal passion projects.
Continual investment to research. -
Community Capability and Engagement
Development of Synapse, an online portal designed for peer-support.
Expand on Community Engagement programs, including MSWA After Hours and other initiatives. -
Innovative Coordinated Care
Establish Client Connect, a fully integrated, nurse-led 24/7 care model delivering needs-based support funded through multiple sources.
Ongoing funding for the NeuroConnect Nurse program.
Completion of MSWA Shenton Park (Montario Quarter).
Foster strong sector partnerships and expand industry connections. -
Translating Research into Outcomes
Joint venture with Founder's Factory to fund and scale breakthrough technologies to support the neuro community.
Improving access to quality care in regional and remote areas.
Support roll out of PLATYPUS, Australia's first adaptive clinical trial.
MSWA on the national stage
Through the dedication of the MSWA team, supporters and volunteers, MSWA made significant strides in achieving positive outcomes, which gained recognition on both local and national scale.